4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-23-006527
EVP, Research and Development acquired 191,462 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Knappertz Volker EVP, Research and Development | 2023-03-02 | Grant or award | +191,462 | 344,274 | D |
Loading xslF345X03/wf-form4_167813808294932.xml…